Advances in Marine Chitin and Chitosan II, 2017

© 2019 by the authors; CC BY license

chitosan; spray-drying; semi-solid formulation; antioxidant encapsulation; chitosan; kappa-carrageenan; vaginal mucoadhesive formulations; acyclovir controlled release; swelling behaviour; cytotoxicity; genital herpes; ex vivo bioadhesion; chitosan; chitosanase; glycoside hydrolase; Streptomyces; Bacillus; Microbacterium; hydrolysis; polysaccharide; chlorovirus; chitosan; genipin; tissue engineering; biomedical uses; biochemical properties; chitosan; Naphthol Green B; Resonance Rayleigh scattering spectra; chitosan; immunoreactivity; endotoxin; immune response; chitosan gallate; molecular architecture; antioxidant activity; grafting; gallic acid; chitosan; physico-chemical properties; molecular weight; degree of acetylation; conformation; antimicrobial activity; from gel to nanobeads; drug delivery; chitosan; chito-oligomers; zeolite; depolymerization; hydrolysis; chitosan; microparticles; glycerol 2-phosphate; spray drying; mucoadhesiveness; cytotoxicity; chitosan; hydrogel; surface grafting; nanocapsules; stability; radiation-induced skin injury; VEGF; chitosan; nanoparticles; apoptosis; squid pen; chitin; homogentisic acid; tryptophan; Paenibacillus; antioxidant; anti-inflammatory; electrospinning; composite fibers; antibacterial properties; protein adsorption; chitin; chitinases; antifungal; marine bacteria; Pseudoalteromonadaceae; Vibrionaceae; chitosan oligosaccharide; propofol; surgery patients; mouse; dorsal root ganglia; voltage-gated sodium channel gene 1.7; chitin oligosaccharides; bio-stimulator; fertilizer; soil biomass; biodiversity; soil health, soil biomass, bio-diversity; Human Immunodeficiency Virus; Acquired Immunodeficiency Syndrome; chitosan; mucoadhesive vaginal tablets; Tenofovir; controlled release; ex vivo bioadhesion; swelling behaviour; swelling witness microstructure; chitooligosaccharides; ion chromatography; inorganic cations and anions; method validation; quantification; chitosan; local delivery; anti-cancer drugs; medical device; chitosan; liposomes; drug delivery; vaginal therapy; Candida albicans; metronidazole; chitin oligosaccharide; antimicrobial prophylaxis; adolescent idiopathic scoliosis; spinal fusion; chitosan; acetylated chitosan oligosaccharides; neuronal disorder; neuroprotection; molecular mechanism; chitosan; gene delivery; drug delivery; adjuvant; cancer; nanoparticle; chitosan oligomer; fluorescent property; metal ion sensor